Patient Guide: A Study to Investigate Vaccine Responses in Subcutaneous Amlitelimab Treated Atopic Dermatitis Participants Aged 18 Years and Older Compared With Placebo

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 57 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06015308
Status: ACTIVE_NOT_RECRUITING
Condition: Dermatitis Atopic
Phase: PHASE2

Where You Can Participate

This study is available at 57 locations across the country.

Top locations include:
  • • Birmingham, Alabama
  • • Scottsdale, Arizona
  • • Anaheim, California
  • • And 54 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study to Investigate Vaccine Responses in Subcutaneous Amlitelimab Treated Atopic Dermatitis Participants Aged 18 Years and Older Compared With Placebo - Join Clinical Trial NCTNCT06015308

How to Join This Clinical Trial - NCTNCT06015308

Learn how to participate in this PHASE2 trial studying an investigational therapy for Dermatitis Atopic. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Dermatitis Atopic. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Dermatitis Atopic
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT06015308 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 57 locations. Find a study site near you:

Clinical Research Site

Birmingham, Alabama 35209 - United States

Status: Contact for availability

Clinical Research Site

Scottsdale, Arizona 85260 - United States

Status: Contact for availability

Clinical Research Site

Anaheim, California 92801 - United States

Status: Contact for availability

Clinical Research Site

Fountain Valley, California 92708 - United States

Status: Contact for availability

Clinical Research Site

Fremont, California 94538 - United States

Status: Contact for availability

Clinical Research Site

Fresno, California 93720 - United States

Status: Contact for availability

Clinical Research Site

La Mesa, California 91942 - United States

Status: Contact for availability

Clinical Research Site

Lafayette, California 94549 - United States

Status: Contact for availability

Clinical Research Site

Lancaster, California 93534 - United States

Status: Contact for availability

Clinical Research Site

Lomita, California 90717 - United States

Status: Contact for availability

And 47 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Dermatitis Atopic:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships